Burnett Patrick

See RemarksArcutis Biotherapeutics, Inc. (ARQT) · full profile →Form 4 · filed Aug 14, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$395K
Net Open-Market Flow
-$395K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 12, 2026Option exercise(M)7K$3.64$24K126K
Aug 12, 2026Sell(S)7K$26.08$175K119K
Aug 11, 2026Option exercise(M)8K$3.64$30K128K
Aug 11, 2026Sell(S)8K$26.52$220K119K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 12, 2026Option exercise(M)7K$0129K
Aug 11, 2026Option exercise(M)8K$0135K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-26-056898) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.